PIK3R1 and cancer: In breast cancer, exosomal miR-221-3p secreted by cancer cells can downregulate phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) and inhibit the PI3K/Akt signaling pathway to promote adriamycin resistance (Pan et al., 2020).